STERIS Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Los beneficios de STERIS han disminuido a una tasa media anual de -6.3%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido creciendo a una tasa media de 15.7% al año. La rentabilidad financiera de STERIS es de 8.8%, y sus márgenes netos son de 10.5%.

Información clave

-6.3%

Tasa de crecimiento de los beneficios

-10.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	8.9%
Tasa de crecimiento de los ingresos	15.7%
Rentabilidad financiera	8.8%
Margen neto	10.5%
Próxima actualización de resultados	08 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Apr 08

Steris: Another Essential Healthcare Supply Resource

Feb 01

Is STERIS (NYSE:STE) A Risky Investment?

Dec 15

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero STERIS. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:STE Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	5,407	567	1,406	105
30 Sep 23	5,228	550	1,352	104
30 Jun 23	5,086	119	1,306	102
31 Mar 23	4,958	107	1,275	102
31 Dec 22	4,784	-28	1,360	101
30 Sep 22	4,777	-8	1,361	101
30 Jun 22	4,773	377	1,369	95
31 Mar 22	4,585	244	1,297	88
31 Dec 21	4,248	279	1,081	79
30 Sep 21	3,848	250	950	71
30 Jun 21	3,407	286	793	68
31 Mar 21	3,108	397	696	66
31 Dec 20	3,057	433	683	66
30 Sep 20	3,022	424	679	66
30 Jun 20	3,003	413	685	66
31 Mar 20	3,031	408	709	66
31 Dec 19	2,976	393	676	64
30 Sep 19	2,898	336	683	63
30 Jun 19	2,840	319	665	62
31 Mar 19	2,782	304	645	63
31 Dec 18	2,730	269	637	65
30 Sep 18	2,696	316	622	65
30 Jun 18	2,651	303	618	63
31 Mar 18	2,620	291	616	61
31 Dec 17	2,585	243	650	59
30 Sep 17	2,570	144	630	58
30 Jun 17	2,582	120	640	59
31 Mar 17	2,613	110	652	59
31 Dec 16	2,616	142	523	58
30 Sep 16	2,588	167	560	58
30 Jun 16	2,431	135	569	57
31 Mar 16	2,233	111	544	57
31 Dec 15	2,042	94	629	57
30 Sep 15	1,897	113	514	57
30 Jun 15	1,870	135	468	55
31 Mar 15	1,842	135	455	54
31 Dec 14	1,807	133	402	52
30 Sep 14	1,739	123	435	49
30 Jun 14	1,660	122	400	49
31 Mar 14	1,615	129	381	49
31 Dec 13	1,585	132	375	49
30 Sep 13	1,560	152	372	48
30 Jun 13	1,533	162	362	44

Ingresos de calidad: STE tiene ganancias de alta calidad.

Margen de beneficios creciente: STE pasó a ser rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de STE han disminuido en un 6.3% al año en los últimos 5 años.

Acelerando crecimiento: STE ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: STE ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (3.3%).

STERIS Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

STERIS plc to Report Q4, 2024 Results on May 08, 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Recent updates

Third quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024

STERIS plc to Report Q4, 2024 Results on May 08, 2024

Steris: Moving On, Losing Its Teeth

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Upcoming dividend of US$0.52 per share at 0.9% yield

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

Second quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024

Now 21% undervalued

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

Now 20% undervalued

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Upcoming dividend of US$0.52 per share at 1.0% yield

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Upcoming dividend of US$0.52 per share at 0.9% yield

When Should You Buy STERIS plc (NYSE:STE)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc to Report Q1, 2024 Results on Aug 01, 2023

Steris: Continuing To Grow The Product Lineup

STERIS plc, Annual General Meeting, Jul 27, 2023

Upcoming dividend of US$0.47 per share at 0.9% yield

Independent Director recently sold US$578k worth of stock

Independent Director exercised options and sold US$785k worth of stock

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.

Insider recently sold US$219k worth of stock

Independent Director exercised options to buy US$863k worth of stock.

Upcoming dividend of US$0.47 per share at 0.9% yield

Third quarter 2023 earnings: Revenues miss analyst expectations

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023

Steris declares $0.47 dividend

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

STERIS plc to Report Q3, 2023 Results on Feb 08, 2023

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Insider recently sold US$308k worth of stock

Upcoming dividend of US$0.47 per share

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: Revenues miss analyst expectations

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

Steris declares $0.47 dividend

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Price target decreased to US$230

STERIS plc to Report Q2, 2023 Results on Nov 09, 2022

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Upcoming dividend of US$0.47 per share

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

First quarter 2023 earnings: EPS and revenues miss analyst expectations

STERIS plc Provides Revenue Guidance for Fiscal 2023

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Steris plc Declares Quarterly Interim Dividend, Payable on September 23, 2022

Desglose de ingresos y gastos
Beta